Skip to Content

TECHNESCAN HDP

Active substance(s): SODIUM OXIDRONATE / SODIUM OXIDRONATE / SODIUM OXIDRONATE

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

ORN 4366
DRN 4366

Technescan HOP United Kingdom & Northern Ireland

Page 1 of 2

Package leaflet: Information for the user

TechneScan® HOP
powder for solution for injection
Active substance: Sodium oxidronate
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What TechneScan(!) HOP is and what it is used for
2. Before you use TechneScan(!) HOP
3. How to use TechneScan(!) HOP
4. Possible side effects
5. How to store TechneScan(!) HOP
6. Further information

1.

What TechneScan® HOP is and what it is
used for

This medicine is for diagnostic use only.
TechneScan(!) HOP is used through a scan to examine the:
• bones.
This medicine is a powder. When mixed by qualified people, with a solution
of the radioactive substance, sodium pertechnetate (99mTc) it forms
Technetium [99mTcj oxidronate. When administered into the body it collects in
certain organs such as , the bones .
The radioactive substance can be photographed from outside the body,
using special cameras which take a scan. This scan shows the distribution of
radioactivity within the organ and body . This also gives the doctor valuable
information about the structure and function of that organ.

Using other medicines
Please tell your doctor or pharmacist if you are taking or ha ve
recently taken any other medicines, including medicines obtained
without a prescription.
The following medicines can particularly influence the TechneScan
HDP examination:
• certain medicines often used as antidotes known as chelates ,
which bind dangerous substances
• medicines to treat reduced bone density with active substance
names usually ending in "dronate', such as alendronate and
risodronate
• tetracycline, a certain medicine used against infections
• aluminium based stomach acid binding medicines
• iron containing medicines , usually used to treat a reduction of red
blood cells

Pregnancy and breast·feeding

2.

• Pregnancy
Tell your doctor if you are pregnant or think you could be. Your
doctor will only administer TechneScan(!) HOP during pregnancy if
it is absolutely necessary, as it could harm the unborn child.

Before you use TechneScan® HOP

Do not use TechneScan®HOP
if you are
• allergic (hypersensitive) to sodium oxidronate or any of the other
ingredients

Take special care with TechneScan ®HOP
This medicine does involve treatment with radioactivity. Your doctor
will only give you this medicine if the benefit outweighs the risk.
TechneScan(!) HOP is given by specialists, who will take responsibility
for any necessary precautions.

• Breast·feeding
Tell your doctor if you are breast-feeding as he may delay
treatment until breast-feeding is finished. He may also ask you to
stop breast·feeding for 4 hours and discard this milk, until the
radioactivity is no longer in your body.
Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines
TechneScan(!) HOP is unlikely to impair the ability to drive and
operate machinery .

Your doctor will inform you if you need to take any special precautions
after using this medicine. Contact your doctor if you have any - - - - - - - - - - - - - - - - - - - - - - questions .

3.

How to use TechneScan® HOP

TechneScan(!) HOP will always be used in a hospital or similar setting. It
will only be administered to you by qualified people trained to safe
handle radioactive material .
Your doctor will decide the TechneScan(!) HOP amount to be used .
The lowest dose possible will be used to produce adequate X- ray
images

The usual dose is:
Approximate doses for adults are:
• 30-700 MBq injected into a vein
MBq is the unit used to measure radioactivity, and defines the
activity of a quantity of radioactive material.

04366006BYS 11a.doe I 26 CON 4366 UK SPC 17102012 I 23 CON 4366 UK PIL 17 1020 12

11111111~mll~'1111111

DRN 4366

Technescan HDP United Kingdom & Northern Ireland

Children under 18 years
Lower doses are used for children according to their body weight.

6.

How many scans
One injection is usually sufficient.

Page 2 of 2

What TechneScan®HOP contains

Avoid strenuous activities after injection until satisfactory scans are
made, as this will ensure efficient use. Scans are made shortly after
the injection , however some scans will not be made earlier than two
hours after the injection.
Drink and urinate as much as possible before and after treat·
ment. This will prevent active substance gathering in the bladder.

If you use more TechneScan® HOP than you should
It is unlikely that overdose will occur as this medicine is given under control
by a doctor. However, if this happens you will receive appropriate treatment
from your doctor.
If you have any further questions on the use of this product, ask your
doctor.

4.

Possible side effects

Like all medicines, TechneScan® HOP can cause side effects, although not
everybody gets them.
.
Side effects can occur with the following frequencies :
very rare, occurs in fewer than 1 per 10,000 users
• severe allergic reactions may occur 4 to 24 hours after injection with
symptoms such as:
- rash
- widening of blood vessels causing flushing or a drop in blood pressure
- breathlessness
- nausea, vomiting
- dizziness or
- pain in the joints
Hospital staff will treat these reactions, if they occur.

Further information

• The active substance is sodium oxidronate.
Each vial contains 3 mg of sodium oxidronate.
• The other ingredients are: gentisic acid, tin(ll)chloride, sodium chloride
and nitrogen.

What TechneScan®HOP looks like and contents of the pack
TechneScan® HOP is a clear to slightly opalescent, colourless aqueous
solution.
TechneScan®MAG3 is packaged in 10 ml type 1 Ph.Eur glass vials closed
with a bromobutyl rubber stopper and sealed with an aluminium crimp cap. It
is supplied in one pack that contains 5 vials.

Marketing Authorisation Holder and Manufacturer
• Marketing Authorisation Holder
Mallinckrodt UK Commercial Ltd .
4500 Parkway, Whiteley, Fareham ,
Hampshire, P015 7NY
United I Tel : +44(0)1329224477, Fax: +44(0)1329224442
PL 41744/0016
• Manufacturer
Mallinckrodt Medical BY , Westerduinweg 3
1755 LE Petten, The Netherlands

This leaflet was last approved in 10/2012.

If any of the side effects gets serious, or if you notice any side effects not
listed in this leaflet, please tell your doctor or pharmacist.

5.

How to store TechneScan® HOP

Do not use TechneScan® HOP after the expiry date stated on the label.
Hospital staff wi ll ensure that the product is correctly stored: not above 25°C
and away from light.

04366006BV$ l1a doe 1 26 CON 4366 UK SPC 17 102012 / 23 CON 4366 UK PIL 1710201 2

1 11111~mlllll'l l l l

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide